WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 2-Jul-2015 (Data received as of 26-June-2015)
Next overall update Mid July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 5301 Infant (under 12 months) mortality rate: 622
GDP / capita (US$): 1'3901 Child (under 5 years) mortality rate: 962

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 6'993  6'817  6'643  6'472  6'306  4'865  3'788  2'721 
Births 251  248  245  241  237  190  161  130 
Surviving infants 235  232  229  225  220  175  147  117 
Pop. less than 5 years 1'116  1'094  1'069  1'045  1'020  806  685  517 
Pop. less than 15 years 2'918  2'853  2'785  2'718  2'653  2'151  1'751  1'263 
Female 15-49 years 1'729  1'685  1'642  1'600  1'559  1'162  845  597 

Number of reported case

(Click for retrospective incidence data for Togo)
Diphtheria
Japanese encephalitis
Measles 577  564  238  187  120  3'578  4'548  33'960 
Mumps
Pertussis 38  30  32  34  53  115  431  3'901 
Polio* 20  178 
Rubella 16  38  33  69  80 
Rubella (CRS)
Tetanus (neonatal) 18  26  20  28  28  33  42  217 
Tetanus (total)** 18  26  20  28  28  107  436 
Yellow fever 12 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Togo)
Vaccine year result method % card seen                                                
BCG 2013  95  DHS   70  79  97  97  90  94  83  99* 
DTP1 2013  93  DHS   70  91  94  94  95  97  66 
DTP3 2013  83  DHS   70  87  84  84  92  92  50  77 
HepB_BD         
HepB3 2013  83  DHS   70  87  84  84  92  92 
Hib3 2013  83  DHS   70  87  84  84  92  92 
JapEnc         
MCV          82  72  72  85  84  43  65 
MCV2         
PCV1          42 
PCV3          34 
Pol3 2013  74  DHS   70  85  84  84  92  92  50  78 
Rota1          35 
Rota_last          35 
Rubella1         
TT2plus 2013  62  DHS   70  80  78  78  86  85  47  35 
PAB         
VAD1          99  89  91  83 
YFV 2013  73  DHS   70  82  72  72  85  84 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Togo)
BCG 97  97  97  97  84  99 
DTP1 94  94  94  97  80  90 
DTP3 84  84  85  83  64  77 
HepB3 84  84  85  83 
HepB_BD
Hib3 84  84  85  83 
MCV 72  72  72  68  58  73 
MCV2
PAB 77  81  81  81  63  47 
PCV3
Pol3 84  84  85  83  63  76 
Rota_last
YFV 72  72  72  67 

Number of districts in the country 40  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 45
From 80 to 89% 40
From 50 to 79% 15
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes From October 2015
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitaminA 9 months; Yes and post-partum women
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011 - 2015  2011 - 2015  2007 - 2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 40  40  35  35  35  35  35 

System performance

Total Nº districts in country number 40  40  35  35  35  35  35 
Nº districts with DTP3 coverage >=80% number 34  37  33  30  31  29  30 
% of districts with DTP3 coverage >=80% From 0 to 100% 85  93  94  86  89  83  86 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 10  20  23  20  26  14 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 25  55  51  45  46  17 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.